Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

172 results about "Respiratory virus" patented technology

Freeze-dried PCR reagent and kit for respiratory virus nucleic acid detection

The invention belongs to the technical field of virus detection, and particularly relates to a freeze-dried PCR reagent and kit for respiratory virus nucleic acid detection. Positive control; performing negative control; the reaction freeze-dried powder comprises an optimized buffer system, Taq DNA polymerase, reverse transcriptase, dNTP / dUTP Mix, a freeze-drying protective agent, a specific primer and a probe; the specific primer and the probe comprise an oligonucleotide upstream primer for specifically amplifying an M gene conserved region on an influenza A virus genome; by preparing reaction freeze-dried powder, an oligonucleotide primer, a probe, Taq DNA polymerase, reverse transcriptase, dNTP, an optimized buffer system, a freeze-drying protective additive and the like are prepared into components which stably coexist at normal temperature, the detection performance is consistent with that of a liquid reagent, normal-temperature transportation and storage can be realized, the transportation and storage cost of the fluorescent PCR reagent is greatly reduced, the shelf life is prolonged, and the fluorescent PCR reagent is suitable for industrial production. And operation steps are reduced.
Owner:JIANGSU JIANWEI DIAGNOSTIC TECH CO LTD

Antiviral and antibacterial N4-hydroxy cytidine derivative as well as application and preparation method thereof

The invention discloses a compound derivative represented by a formula I or an isotope labeled compound thereof, or an optical isomer, a geometric isomer, a tautomer or an isomer mixture thereof, or a pharmaceutically acceptable salt thereof. According to the application of a double protection strategy, diversified carrier fragments are introduced to 5-hydroxyl and hydroxylamine in N4-hydroxycytidine molecules, the N4-hydroxycytidine prodrug is invented, the affinity of lung cell membranes (phospholipid membranes) is improved, and the physicochemical properties of the drug are made to meet the requirements of the physiological environment of lung tissue. Therefore, the compound disclosed by the invention has a wide application prospect in the aspect of broad-spectrum respiratory virus resistance. # imgabs0 #
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Combination exosome immunogenic compositions and methods

The present disclosure relates to compositions and methods for vaccinating a subject against a variety of SARS-CoV-2 variants and other respiratory viruses, the compositions and methods involve preparing and delivering extracellular vesicles expressing on its surface an engineered spike protein, an engineered nucleocapsid protein, an engineered hemagglutinin protein, and / or an engineered respiratory syncytial virus pre-fusion or fusion (RSV F) protein. The invention also relates to compositions and methods for designing, preparing, making, formulating and / or using spike display, nucleocapsid display, hemagglutinin display and / or RSV F display vesicle vaccines, the spike display, nucleocapsid display, hemagglutinin display, and / or RSV F display vesicle vaccines are designed to elicit potent humoral and cellular immune responses against a variety of respiratory viruses and variants.
Owner:CAPRICOR INC

Preparation method of triple detection kit for influenza A, influenza B and new coronavirus antigens

The invention discloses a preparation method of a triple detection kit for influenza A, influenza B and new coronavirus antigens, and belongs to the field of respiratory virus in-vitro detection. In the antibody labeling stage, the antigen and the antibody can be more sufficiently combined in a manner of adding the linking arm, so that the antigen detection sensitivity can be improved. In the metal spraying stage, a novel coronavirus monoclonal antibody, an influenza A virus monoclonal antibody and an influenza B virus monoclonal antibody marked by latex microspheres are sequentially subjected to multi-layer metal spraying at the same position by a metal spraying instrument, the two antibodies are isolated by a trehalose solution, and metal spraying of three layers of antibodies isolated from each other is completed. And the cross reaction between different antibodies of the conjugate pad in the storage process is avoided, so that non-specific binding is avoided, and the storage stability is improved. The detection kit prepared by the method can specifically detect the novel coronavirus, the influenza A virus and the influenza B virus, and has the advantages of high sensitivity, good repeatability and the like.
Owner:BAODING ABIORES CHIP CO LTD +1

Methods and kits for virus detection

The invention relates to methods and kits for detecting a virus, e.g., a respiratory virus such as a coronavirus, in a biological sample. The invention also relates to methods and kits for detecting and / or quantifying biomarkers, e.g., antibody biomarkers against a viral antigen; inflammatory and / or tissue damage response biomarkers; and / or extracellular vesicles in response to a viral infection.
Owner:MESO SCALE TECH LLC

Method for producing pecticoligosaccharides by microbial degradation of pomace and application thereof

The application discloses a method for producing pectin oligosaccharides by microbial degradation of pomace and application thereof. The method comprises the following steps: adding microbacterium A5 to a culture medium containing pomace to perform fermentation to obtain a fermentation liquor, performing fractional pressing filtration and filter sterilization on the fermentation liquor, performing ethanol precipitation to extract a pectin crude product, removing protein, performing ion exchange chromatography, dialysis desalting, freeze drying and the like to purify two pectin oligosaccharides POS-1 and POS-2 with a purity greater than 95%; the pectin oligosaccharides POS-1 and POS-2 have strong scavenging capacity on hydroxyl radicals and DPPH free radicals and the capacity of inhibiting the activity of respiratory RNA viruses such as influenza virus H1N1 and respiratory syncytial virus RSV, and can be applied to medicines or health foods.
Owner:JINAN UNIVERSITY

Vaccine composition against two respiratory viruses

The present invention relates to a viral strain derived from a human metapneumovirus (hMPV) strain having a genomic sequence represented by sequence SEQ ID NO: 1 wherein the genomic sequence comprises the following genetic modifications: (i) inactivating an endogenous gene encoding an SH protein and / or a G protein, and (ii) the presence of an exogenous sequence encoding at least one extracellular domain of an F protein of a human respiratory syncytial virus (hRSV), the domain is of a wild type or mutant.
Owner:WAXEL +6

Dry powder composition for peroral administration

There is provided a pharmaceutical dosage form that is suitable for peroral administration to the gastrointestinal tract, which dosage form comprises a pharmaceutical composition in the form of a particulate mixture comprising solid particles of N-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide (C21), or a pharmaceutically-acceptable salt thereof, admixed with a blend of carrier particles with weight- and / or a volume-based mean diameter, and / or a structural / particle density, that is / are similar to the weight- and / or volume-based mean diameter, and / or the structural / particle density, of the solid particles of C21, and a glidant, which composition is contained within a capsule that is suitable for such peroral administration. Preferred carrier particles have a weight- and / or a volume-based mean diameter that is less than about 100 μm. Preferred carrier particle materials include mannitol. Preferred glidants comprise colloidal silica. Such dosage forms find utility in the treatment of lung diseases, such as idiopathic pulmonary fibrosis, sarcoidosis and respiratory virus-induced tissue damage.
Owner:VICORE PHARMA AB

Raman-enhanced nano-label based on polydopamine core-shell structure, preparation method and application of Raman-enhanced nano-label in immunochromatography

The invention provides a Raman enhanced nano-label based on a polydopamine core-shell structure, a preparation method and application of the Raman enhanced nano-label in immunochromatography, and relates to the technical field of immunochromatography. The Raman enhanced nano-label based on the polydopamine core-shell structure sequentially comprises a PDA microsphere core, a PEI layer and a gold and silver nano-particle layer from inside to outside, the gold and silver nanoparticle layer is gold and silver nanoparticles with a core-shell structure; the gold and silver nanoparticle layer is connected with a Raman signal molecule DTNB, and a terminal carboxyl group of the Raman signal molecule DTNB is coupled with a capture antibody of an H1N1 virus or a capture antibody of an SARS-CoV-2 virus. The nano-label has colorimetric and SERS enhanced activity at the same time, has the advantages of rich hot spots, high stability, excellent optical performance and the like, is used for an immunochromatography sensor to detect two respiratory viruses at the same time, adopts qualitative and quantitative dual-mode detection, and improves the detection flexibility, sensitivity and accuracy.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Respiratory virus sampling device

The utility model belongs to the field of medical instruments, and particularly relates to a respiratory virus sampling device which comprises a handle, the interior of the handle is connected with a separation assembly, and the left end of the handle is connected with a sampling assembly; through the structural design of the separating assembly, after sampling is finished, the two operating rods are pushed from the right end of the handle to the middle, the operating rods can be driven to slide towards the middle along the connecting rod, so that the spring is driven to be compressed, the limiting rod is separated from the limiting groove, the handle can be directly separated from the sampling rod, and operations such as breaking are not needed; the device has the advantages of simple structure, convenience and rapidness in separation and no splashing of liquid in a sample bottle due to uneven force, and solves the problems that a sample is possibly damaged due to the fact that the breaking force is possibly difficult to control in operation when a sampling swab head is taken down in a breaking manner in a comparison patent. And the liquid in the sample bottle can be splashed due to the applied force during breaking, so that the sampling safety is easily influenced.
Owner:TIANJIN MAILUO MEDICAL LAB CO LTD

A method for chemiluminescence detection of RNA pathogens based on nucleic acid structure and sequence characteristics

The present application relates to the technical field of nucleic acid detection, in particular to a RNA pathogen chemiluminescence detection method based on nucleic acid structure and sequence characteristics. The present application provides a pathogen RNA rapid detection technology based on the reporter molecule cyclization combined with rolling circle amplification according to the secondary structure and sequence characteristics of RNA, which is suitable for high-sensitivity and high-specificity detection of RNA pathogens such as respiratory viruses. The present application innovatively combines the target structure characteristics with sequence specificity, breaks through the traditional sequence-dependent isothermal amplification technology, realizes the highly specific reporter molecule cyclization, significantly improves the detection reliability, and does not require complex instruments. After the swab sample is collected, the pathogen RNA is rapidly released by using a nucleic acid releasing agent, without complex purification steps, and the reading can be realized through a common chemiluminescence instrument, which is suitable for primary site detection.
Owner:JILIN UNIVERSITY

A method and system for predicting immune response after respiratory viral infection using traditional Chinese medicine

This invention relates to the field of immune prediction technology and discloses a method and system for predicting immune responses after respiratory virus infection using traditional Chinese medicine. The method includes: acquiring an infection dataset; constructing patient markers based on the infection dataset, constructing infection markers based on the number of respiratory virus infections, determining data relationships based on patient markers, infection markers, and a disease course sliding window, and mapping fields in the infection dataset; extracting clinical phenotypic features based on status, infection, and immunity fields, matching detection item identifiers, determining multi-omics features, determining immune repertoire features based on genes and gene sequences, and determining features based on the four diagnostic methods of traditional Chinese medicine; and determining the predicted immune response after respiratory virus infection based on an intelligent immune response prediction model. This invention ensures the accuracy of predicting immune responses after respiratory virus infection using traditional Chinese medicine.
Owner:TIANJIN UNIV OF TRADITIONAL CHINESE MEDICINE

Nucleic acid influenza vaccines and respiratory virus combination vaccines

Some aspects of the disclosure relate to vaccines (e.g., RNA vaccines (e.g., mRNA vaccines)) for seasonal influenza viruses as well as methods of using the vaccines. Also described are combination vaccines (e.g., RNA vaccines (e.g., mRNA vaccines)) for seasonal influenza viruses and other respiratory viruses (e.g., respiratory syncytial viruses and coronaviruses), as well as methods of using the vaccines.
Owner:MODERNATX INC

A three-channel electrochemiluminescence test strip for detecting influenza virus and adenovirus, its preparation method and application

This invention relates to a three-channel electrochemiluminescence test strip for detecting influenza virus and adenovirus, its preparation method, and its application. The test strip comprises a paper-based channel layer and an electrode layer; the paper-based channel layer includes three detection channels, each comprising a sample pad, a conjugate pad, a detection pad, and an absorbent pad arranged sequentially. The electrode layer has several electrodes, and the detection areas of the electrodes are fixed in the same position as the detection pads. This invention designs a paper-based electrochemiluminescence detection scheme, successfully constructing a paper-based electrochemiluminescence detection platform with high sensitivity, high specificity, multiplex detection capability, and good stability, effectively solving the application bottleneck of existing respiratory virus detection technologies in rapid on-site screening.
Owner:ZHUHAI DISEASE PREVENTION & CONTROL CENT

Instant detection kit for differential diagnosis of respiratory viruses

The invention relates to the field of biological detection, and particularly discloses a real-time detection kit for differential diagnosis of respiratory viruses, the real-time detection kit comprises a working shell, the working shell is detachably connected with a detection shell, and the detection shell is provided with a communication assembly; a plurality of detection assemblies communicated with the communication assembly are arranged on the detection shell, and a flow limiting assembly is arranged on the communication assembly; and a rotating assembly filled with a buffer solution is connected between the working shell and the communicating assembly. The purpose of mixed detection of multiple viruses of multiple infected persons can be achieved, the effect of integrated detection of the kit can be achieved, participation of medical staff is reduced, the labor intensity of the medical staff is reduced, the detection efficiency is improved, detection operation is conducted in a closed environment, the phenomenon of splashing of a buffer solution is reduced, and the detection accuracy is improved. The possibility of virus leakage is reduced, the phenomenon of cross infection of crowds is reduced, and meanwhile, the kit is disinfected, so that the virus epidemic situation can be controlled.
Owner:JILIN CHONGMING BIOTECHNOLOGY CO LTD

RNA pathogen chemiluminescence detection method based on nucleic acid structure and sequence characteristics

The invention relates to the technical field of nucleic acid detection, in particular to an RNA pathogen chemiluminescence detection method based on a nucleic acid structure and sequence characteristics. The invention provides a pathogen RNA rapid detection technology which is based on RNA secondary structure and sequence characteristic reporter molecule cyclization and is combined with rolling circle amplification, and is suitable for high-sensitivity and high-specificity detection of RNA pathogens such as respiratory viruses. Target structure characteristics and sequence specificity are creatively combined, a traditional sequence-dependent isothermal amplification technology is broken through, high-specificity reporter molecule cyclization is achieved, the detection reliability is remarkably improved, complex instruments are not needed, after swab samples are collected, pathogen RNA is rapidly released through a nucleic acid releasing agent, complex purification steps are not needed, and the method is suitable for large-scale popularization and application. And reading can be realized through a common chemiluminiscence instrument, and the method is suitable for base-level field detection.
Owner:JILIN UNIVERSITY

Quinoline triazole compound and application thereof

PendingCN121930210AGood anti-influenza activityActivity hasOrganic active ingredientsOrganic chemistryQuinolineRespiratory virus
The invention relates to a quinoline triazole compound and application thereof. The quinoline triazole compound has the structural characteristics as shown in formula I, and can effectively treat diseases caused by respiratory viruses such as influenza.
Owner:GUANGZHOU NAT LAB +1

Vaccine composition comprising an antigen and a TLR3 agonist

A vaccine composition comprising one or more proteins expressed on the surface of a respiratory virus or bacterium and one or more pharmaceutically acceptable excipient, wherein the composition is in particulate form having a mean particle size in a range of from 2 to 50 μm. The protein is contained in the composition in its correctly folded three-dimensional structure.
Owner:ISR IMMUNE SYST REGULATION HLDG AB (PUBL)

A respiratory virus rapid detection kit based on ZIF-8 material and a preparation method thereof

The application relates to the field of microorganism detection, in particular to a respiratory virus rapid detection kit based on ZIF-8 material and a preparation method, wherein the kit comprises a virus collecting device, an exhalation cylinder and a ZIF-8 membrane, the ZIF-8 membrane is detachably arranged in the exhalation cylinder, the ZIF-8 membrane comprises a chitosan layer, the chitosan layer is uniformly distributed with ZIF-8 material, virus particles in the exhaled gas of a tester through the exhalation cylinder are adsorbed, a sample processing device comprises a processing liquid, the processing liquid elutes and lyses the virus particles adsorbed by the ZIF-8 material distributed on the chitosan layer, and a virus processing liquid is obtained, a detection reagent is used for detecting the virus processing liquid and giving a detection result, sampling is simple and rapid, the detection can be completed without the participation of professionals, sampling efficiency is higher, and the detection sensitivity is effectively improved.
Owner:SHANGHAI KANGLI DIAGNOSTIC TECH CO LTD

Storage box (for respiratory virus sampling)

1. Name of the design product: Preservation box (for respiratory virus sampling). 2. Use of the design product: Sample preservation for respiratory virus sampling. 3. Design key points of the design product: Lies in the shape. 4. Picture or photograph that best shows the design key points: Perspective view.
Owner:JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION (PUBLIC HEALTH RESEARCH INSTITUTE OF JIANGSU PROVINCE)

Monoclonal antibody capable of simultaneously identifying multiple pedigree of porcine reproductive and respiratory syndrome virus GP5 protein

The invention belongs to the technical field of biology, and discloses a monoclonal antibody capable of simultaneously recognizing multiple pedigree of porcine reproductive and respiratory syndrome virus GP5 protein. The invention discloses a recombinant protein. The recombinant protein is formed by repeatedly connecting two short peptides in series. The GP5 protein is a basis for dividing a PRRSV pedigree, the GP5 protein is taken as a research object, two regions with relatively strong immunogenicity on amino acid of the GP5 protein are repeatedly connected in series, and the two regions are further connected in series with a tag sequence or a Foldon oligopeptide to obtain a recombinant protein. The recombinant protein is used as an immunogen, and a monoclonal antibody capable of simultaneously identifying GP5 proteins of a plurality of pedigree (including pedigree 1, pedigree 3, pedigree 5 and pedigree 8) of PRRSV is prepared and screened.
Owner:GUANGDONG HAID GROUP +1

Monoclonal antibodies, detection reagents and applications thereof for detecting human metapneumovirus

The present invention relates to a monoclonal antibody, a detection reagent and an application thereof for detecting human metapneumovirus. The monoclonal antibody or an antigen-binding fragment thereof of the present invention can specifically bind to the N protein of human metapneumovirus with high affinity, has a broad spectrum of effectiveness against various genotypes, and has no cross-reactivity with other respiratory viruses. Therefore, it has great potential application value in clinical detection of human metapneumovirus infection.
Owner:CAPITAL INST OF PEDIATRICS

Use of sialylated IVIG or IGG FC region-containing protein for preventing or treating respiratory virus diseases

In one aspect, provided herein are methods for preventing and / or treating respiratory virus diseases (e.g., moderate to severe respiratory virus diseases) comprising administering to a subject (e.g., a human subject) hypersialylated intravenous immunoglobulin (IVIg), a protein comprising a sialylated IgG Fc region, or a protein comprising a modified IgG Fc region that mimics IgG Fc sialylation. In another aspect, provided herein are methods for improving lung function or preserving lung function in a subject with a respiratory virus disease (e.g., moderate to severe respiratory virus diseases) comprising administering to a subject (e.g., a human subject) hypersialylated intravenous immunoglobulin (IVIg), a protein comprising a sialylated IgG Fc region, or a protein comprising a modified IgG Fc region that mimics IgG Fc sialylation.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV

Application of Liriope platyphylla Saponin C in the preparation of anti-respiratory virus drugs

The present invention provides the use of liriope muscari saponin C in the preparation of anti-respiratory virus drugs, belonging to the field of antiviral drug preparation. The liriope muscari saponin C of the present invention shows different degrees of inhibitory effects on influenza virus (H1N1) and novel coronavirus (SARS-CoV-2), showing good antiviral application prospects. Liriope muscari saponin C effectively inhibits the replication of influenza virus and the infection of SARS-CoV-2 to host by inhibiting the nuclear translocation of influenza virus vRNP complex and the binding of SARS-CoV-2 S protein and ACE2.
Owner:LANZHOU UNIV

Drainage mechanism for condensing cup of breathing machine

The utility model relates to a breathing machine condensation cup drainage mechanism which is used in the field of breathing machine parts. According to the technical scheme, a drainage port is formed in the lower portion of the condensation cup and connected with a drainage short pipe, a water valve switch is arranged on the drainage short pipe, and a connector is arranged at the lower end of the water valve switch. Condensate water in the condensation cup can be effectively discharged, and backflow caused by too high water level is avoided; the problem of aerogel pollution caused by drainage in a detachable mode is solved, the device can be popularized and used in hospitals at present, and the transmission risk of respiratory viruses is reduced.
Owner:郑友亮

Antiviral and antibacterial n4-hydroxycytidine derivative, and use thereof and preparation method therefor

Disclosed in the present invention are a compound derivative represented by formula I or an isotopically labeled compound thereof, or an optical isomer, geometric isomer, tautomer or mixture of isomer thereof, or a pharmaceutically acceptable salt thereof. On the basis of the application of a dual-protection strategy, diverse carrier fragments are introduced at the 5-hydroxyl group and hydroxylamine group of the N4-hydroxycytidine molecule to develop an N4-hydroxycytidine prodrug. Such a modification enhances the affinity for a pulmonary cell membrane (phospholipid membrane), rendering the physicochemical properties of the drug suitable for the physiological environment of lung tissue. Therefore, the compound of the present invention has a broad application prospect in the aspect of broad-spectrum anti-respiratory viruses.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Fluorescent PCR kit and method for detecting respiratory virus

The present application relates to the field of molecular biology detection, in particular to a fluorescent PCR kit and a detection method for respiratory virus detection. The present application constructs specific primer groups and probes for detecting respiratory viruses, including influenza A virus, influenza B virus, human parainfluenza virus type I, human parainfluenza virus type II, human parainfluenza virus type III, respiratory syncytial virus and metapneumovirus. Through a matching PCR system, the simultaneous detection of multiple respiratory pathogens is realized in a single-color detection channel by using the melting curve and the characteristic peak of the melting temperature as indicators. The present application at least doubles the existing fluorescent PCR detection throughput, has low cost, short time consumption, greatly improves the detection efficiency, and can be widely used for mixed detection and analysis of multiple pathogens. The detection results can be further used for assisting clinical diagnosis and treatment.
Owner:AUTOBIO DIAGNOSTICS CO LTD

Method and equipment for disinfecting and killing respiratory viruses by spatially spraying hydroxyl free radical liquid drops

The invention relates to a method and equipment for rapidly killing respiratory viruses by spatially spraying hydroxyl free radical droplets, and the method comprises the following steps: introducing oxygen O2 into an oxygen plasma generation source, and applying high-frequency and high-voltage excitation to the oxygen plasma generation source to generate high-concentration oxygen active particles; oxygen active particle gas is injected into the jet mixer, a large number of ultra-fine bubbles are generated through the water jet cavitation effect, OH is efficiently generated at the instant high temperature and high pressure of explosion of the ultra-fine bubbles and under the action of pressure shock waves of backfilling holes, and then the OH flows into the second-stage baffling mixing and dissolving device to generate a high-concentration OH solution; the OH solution is sheared by high-pressure jet flow of the spray head to form OH liquid drops, and the liquid drops are contacted, collided, broken and spread to instantly kill pathogenic microorganisms including respiratory viruses; the intelligent control system performs real-time state sensing and intelligent control, fault diagnosis, prediction and early warning, cloud service and remote monitoring.
Owner:TIANJIN UNIV